Davunetide: Peptide Therapeutic in Neurological Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|23|2591-2598

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.23, 2014-08, pp. : 2591-2598

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Vasoactive Intestinal Peptide and its Receptors in Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 661-666

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategy of Erythropoietin in Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-06 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Potential of Statins in Neurological Disorders

By  

Current Medicinal Chemistry, Vol. 14, Iss. 1, 2007-01 ,pp. : 103-112

Bentham Science Publishers

Access to resources Recommend Favorite

A Translational View of Peptide Treatment of Neurological Disorders

By Brinker Thomas   Spader Heather  

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-08 ,pp. : 2583-2590

Bentham Science Publishers

Access to resources Recommend Favorite

A Translational View of Peptide Treatment of Neurological Disorders

By  

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-08 ,pp. : 2583-2590

Bentham Science Publishers

Access to resources Recommend Favorite